XML 47 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Stock Awards Granted

The following table summarizes the Company’s stock awards granted for each of the periods indicated:

 

 

 

For the Three Months Ended March 31,

 

 

 

2017

 

 

2016

 

 

 

Grants

 

 

Weighted Average Grant Date Fair Value

 

 

Grants

 

 

Weighted Average Grant Date Fair Value

 

Stock options

 

 

877,492

 

 

$

16.30

 

 

 

1,205,776

 

 

$

11.92

 

Restricted stock units (1)

 

 

161,029

 

 

$

32.63

 

 

 

 

 

$

 

Restricted stock awards

 

 

6,500

 

 

$

31.06

 

 

 

25,775

 

 

$

13.71

 

 

 

(1)

The Company granted certain executives 156,029 restricted stock units (“RSU”) with certain sales target and regulatory milestones. As of March 31, 2017, the performance conditions of these RSUs were not probable of being achieved. If and when deemed probable that such performance milestones may be achieved within the required time frame, the Company may recognize up to $5.1 million of stock-based compensation related to these grants. The remaining RSUs are service-based awards granted to the members of the board of directors.   

Summary of Stock-Based Compensation Expense by Function Included within Condensed Consolidated Statement of Operations and Comprehensive Loss

The following table summarizes stock-based compensation expense by function included within the unaudited condensed consolidated statements of operations and comprehensive loss:

 

 

 

For the Three Months Ended

March 31,

 

 

 

2017

 

 

2016

 

 

 

(in thousands)

 

   Research and development

 

 

1,874

 

 

 

2,449

 

   General and administrative

 

 

3,838

 

 

 

4,241

 

Total stock-based compensation expense

 

$

5,712

 

 

$

6,690

 

 

Summary of Stock-Based Compensation Expense by Grant Type Included within Condensed Consolidated Statement of Operations and Comprehensive Loss

 

The following table summarizes stock-based compensation expense by grant type included within the unaudited condensed consolidated statements of operations and comprehensive loss:

 

 

 

For the Three Months Ended

March 31,

 

 

 

2017

 

 

2016

 

 

 

(in thousands)

 

   Stock options

 

$

5,038

 

 

$

5,698

 

   Restricted stock awards/units

 

 

204

 

 

 

184

 

   Stock appreciation rights

 

 

 

 

 

115

 

   Employee stock purchase plan

 

 

470

 

 

 

693

 

Total stock-based compensation expense

 

$

5,712

 

 

$

6,690